BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

2:28 PM
 | 
Jun 25, 2019
 |  BC Extra  |  Company News

WuXi AppTec raising U.S. profile to counter political attacks

WuXi AppTec plans to raise its profile in the U.S. in the hope that a better understanding of its activities will de-escalate political attacks on the company, co-CEO Edward Hu told BioCentury.

While restrictions on Chinese investment in life sciences companies and U.S.-China trade tensions have not curtailed the activities of WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359), they have shaken investor confidence. WuXi’s stock has slipped 8% to HK$64 since June 20 following congressional attacks on Chinese life sciences companies and investors (see “Fearmongering about China”).

WuXi has kept a low profile in the U.S., Hu said.

But now it wants to highlight its role in enabling innovation by U.S.-based biopharma companies, as an employer, and as a promoter of economic development.

“Maybe we have been too low profile, not spending enough time educating on WuXi's role and contribution to the life sciences industry,”...

Read the full 720 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >